Screening for hepatitis C virus infection in adults: Recommendation statement

被引：43

作者：

Berg, AO ^{[1
]}

Allan, JD

Orleans, CT

Siu, AL

Teutsch, SM

Westhoff, C

Woolf, SH

机构：

[1] US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA

[2] Univ Maryland, Baltimore, MD 21201 USA

[3] Colorado Dept Publ Hlth & Environm, Denver, CO USA

[4] Univ Rochester, Rochester, NY USA

[5] Tri Cty Family Med, Cohocton, NY USA

[6] Pan Amer Hlth Org, Washington, DC USA

[7] Univ N Carolina, Sch Med, Chapel Hill, NC USA

[8] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA

[9] Univ Rochester, Sch Med, Rochester, NY USA

[10] Univ Michigan, Ann Arbor, MI 48109 USA

[11] Univ Texas, Houston, TX USA

[12] Robert Wood Johnson Fdn, Princeton, NJ 08540 USA

[13] Mt Sinai Sch Med, New York, NY USA

[14] Merck & Co Inc, West Point, PA USA

[15] Columbia Univ, New York, NY USA

[16] Virginia Commonwealth Univ, Fairfax, VA USA

来源：

ANNALS OF INTERNAL MEDICINE | 2004年 / 140卷 / 06期

关键词：

D O I：

10.7326/0003-4819-140-6-200403160-00013

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on screening for hepatitis C virus (HCV) infection, which are based on the USPSTF's examination of evidence specific to asymptomatic persons for HCV testing and treatment. The complete information on which this statement is based, including evidence tables and references, is available in the accompanying article in this issue and in the summary of the evidence and systematic evidence review on this topic.

引用

页码：462 / 464

页数：3